Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|March 9, 2025
Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programmeJorune Balciuniene, Saliha Yilmaz, Satheesh Chonat, et al.
Cold Spring Harbor Molecular Case Studies|August 24, 2016
Exome sequencing results in successful diagnosis and treatment of a severe congenital anemiaJessica N Lacy, Jacob C Ulirsch, Rachael F Grace, et al.
BMJ Open|August 28, 2021
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocolKristin A Shimano, Rachael F Grace, Jenny M Despotovic, et al.
British Journal of Haematology|August 9, 2024
Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak RegistryAndreas Glenthøj, Rachael F Grace, Carl Lander, et al.
British Journal of Haematology|July 21, 2026
Avatrombopag for persistent and chronic immune thrombocytopenia in children: A post hoc analysis of clinical characteristics of response from a phase 3b clinical trialRachael F Grace, Göksel Leblebisatan, Yesim Aydinok, et al.
Frontiers in Cardiovascular Medicine|January 10, 2022
Biocompatibility and Application of Carbon Fibers in Heart Valve Tissue EngineeringYuan-Tsan Tseng, Nabil F Grace, Heba Aguib, et al.
Pediatric Blood & Cancer|December 29, 2022
Pediatric refractory immune thrombocytopenia: A systematic reviewLayan Ibrahim, Selina X Dong, Katie O'Hearn, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2017
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemiaRachael F Grace, Daniel J DeAngelo, Kristen E Stevenson, et al.
Haematologica|October 15, 2020
The variable manifestations of disease in pyruvate kinase deficiency and their managementHanny Al-Samkari, Eduard J Van Beers, Kevin H M Kuo, et al.
Pediatric Blood & Cancer|March 25, 2021
Quality of life is an important indication for second-line treatment in children with immune thrombocytopeniaKristin A Shimano, Cindy Neunert, James B Bussel, et al.
Pageof 14